A detailed history of Octagon Capital Advisors LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 1,180,798 shares of DYN stock, worth $33.9 Million. This represents 9.63% of its overall portfolio holdings.

Number of Shares
1,180,798
Previous 1,242,945 5.0%
Holding current value
$33.9 Million
Previous $35.3 Million 18.09%
% of portfolio
9.63%
Previous 5.52%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$23.65 - $35.63 $1.47 Million - $2.21 Million
-62,147 Reduced 5.0%
1,180,798 $41.7 Million
Q1 2024

May 15, 2024

BUY
$13.06 - $29.18 $5.88 Million - $13.1 Million
450,000 Added 56.75%
1,242,945 $35.3 Million
Q4 2023

Feb 14, 2024

BUY
$6.62 - $13.64 $662,000 - $1.36 Million
100,000 Added 14.43%
792,945 $10.5 Million
Q1 2023

May 15, 2023

BUY
$10.88 - $15.0 $7.54 Million - $10.4 Million
692,945 New
692,945 $7.98 Million
Q2 2022

Aug 15, 2022

SELL
$4.36 - $10.5 $2.29 Million - $5.52 Million
-525,284 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.52 - $12.27 $380,539 - $716,138
-58,365 Reduced 10.0%
525,284 $5.06 Million
Q1 2021

May 17, 2021

BUY
$14.0 - $29.3 $1.43 Million - $2.99 Million
102,111 Added 21.21%
583,649 $9.06 Million
Q4 2020

Feb 16, 2021

BUY
$16.81 - $23.94 $8.09 Million - $11.5 Million
481,538 New
481,538 $10.1 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.49B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.